General Information of the Compound
Compound ID
CP0487117
Compound Name
(6S,9S,12R,17R,20S,23S,26S,29S,32S)-12-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-acetamidoacetyl)amino]acetyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-N-[(2S)-5-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-2-oxoethyl]-methylamino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1,5-dioxopentan-2-yl]-29-[(2S)-butan-2-yl]-23-[(2-fluorophenyl)methyl]-26-[(1R)-1-hydroxyethyl]-9-(1H-imidazol-5-ylmethyl)-6-(2-methylsulfanylethyl)-2,5,8,11,19,22,25,28,31-nonaoxo-20-propan-2-yl-14,15-dithia-1,4,7,10,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-17-carboxamide
    Show/Hide
Structure
Formula
C103H160FN29O25S3
Molecular Weight
2319.79
Canonical SMILES
CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2F)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N(C)CC(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(C)=O
    Show/Hide
InChI
InChI=1S/C103H160FN29O25S3/c1-14-56(8)84-99(155)130-85(58(10)134)100(156)125-72(43-61-22-15-16-23-64(61)104)93(149)128-83(55(6)7)98(154)127-75(94(150)121-68(32-33-78(106)137)102(158)133-38-21-27-77(133)96(152)124-70(41-54(4)5)91(147)120-67(25-19-36-111-103(108)109)101(157)131(12)49-81(140)117-65(86(107)142)24-17-18-35-105)51-161-160-50-74(95(151)123-73(44-62-45-110-52-115-62)92(148)119-66(34-39-159-13)88(144)114-48-82(141)132-37-20-26-76(132)97(153)129-84)126-87(143)57(9)116-89(145)71(42-60-28-30-63(136)31-29-60)122-90(146)69(40-53(2)3)118-80(139)47-113-79(138)46-112-59(11)135/h15-16,22-23,28-31,45,52-58,65-77,83-85,134,136H,14,17-21,24-27,32-44,46-51,105H2,1-13H3,(H2,106,137)(H2,107,142)(H,110,115)(H,112,135)(H,113,138)(H,114,144)(H,116,145)(H,117,140)(H,118,139)(H,119,148)(H,120,147)(H,121,150)(H,122,146)(H,123,151)(H,124,152)(H,125,156)(H,126,143)(H,127,154)(H,128,149)(H,129,153)(H,130,155)(H4,108,109,111)/t56-,57-,58+,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,83-,84-,85-/m0/s1
    Show/Hide
InChIKey
VTEYOJJPKQGFET-GYKFKOCVSA-N
Physicochemical Property
logP
-6.15063
Rotatable Bonds
51
Heavy Atom Count
161
Polar Areas
827.97
Hydrogen Bond Donor Count
27
Hydrogen Bond Acceptor Count
31
Complexity
161

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145986198
ChEMBL ID
CHEMBL4244160
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01825, Erythropoietin receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000128 TF-1 Homo sapiens (Human)  1
1
EC50 = 540 nM
   TI
   LI
   LO
   TS